Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Apr 29, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how COVID-19 affects children, particularly those who have cancer. Researchers want to learn more about the virus, including how it spreads and who is most at risk of getting sick. To do this, they are asking children under 24 years old, who have been diagnosed with COVID-19 at St. Jude, to provide respiratory and blood samples. The goal is to gather important information that could help doctors better understand and treat COVID-19 in the future.
If your child is eligible and chooses to participate, they will be involved in a study that focuses on understanding their specific symptoms and the overall impact of the virus. Participants will help researchers learn about the immune response to the virus and how long it stays in their bodies. It's important to know that the trial is currently recruiting participants, and there are no exclusions based on other health conditions. This research could lead to better detection and treatment options for COVID-19 in children.
Gender
ALL
Eligibility criteria
- Patient Participant Inclusion Criteria:
- • Less than 24 years old at the time of enrollment on study.
- • St. Jude patients with laboratory confirmed Covid-19.
- Exclusion Criteria:
- • NA
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier pediatric research institution dedicated to advancing the treatment and understanding of catastrophic diseases in children, particularly cancer and other life-threatening conditions. Renowned for its innovative clinical trials and cutting-edge research, St. Jude integrates patient care with scientific discovery to develop new therapies and improve outcomes for young patients. The hospital is committed to ensuring that no family receives a bill for treatment, travel, housing, or food, fostering a holistic approach to pediatric care. Through collaboration with global research networks, St. Jude aims to share its findings and expertise to enhance treatment options worldwide, making significant strides in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Diego Hijano, MD
Principal Investigator
St. Jude Children's Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials